Navigation Links
XTL in Medical News

Notification of Annual General Meeting and Extraordinary General Meeting

...ty's site: http://www.magna.isa.gov.il . ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007

...ital well into the first quarter of 2009." ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Announces Delisting From the Official List of the United Kingdom Listing Authority

...SDAQ, or trade their ordinary shares on the TASE. xtl Biopharmaceuticals Ltd. has further announced that...1-212-815-3004, jpaltrowitz@bankofny.com About xtl Biopharmaceuticals Ltd. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...
XTL in Medical Technology

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...EHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XT...ent for a severe and incurable blood cancer. We at xtl are thrilled at this opportunity and expect to emb...ce with the terms of the asset purchase agreement, xtl will issue Bio-GAL Ltd. ordinary shares representi...

XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain

...rly await the outcome of this study in Q4 2008." xtl in-licensed the world-wide rights to Bicifadine fr..., Inc. (NASDAQ OTC: DOVP) in January 2007. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis

...gnificant side affects associated with it. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...ics for the treatment of neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Provides Update on Phase I Clinical Trial of XTL-2125

... New York, June 06, 2007 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. announced today that it ha...rved in the placebo group. Based on these results, xtl has decided to suspend further development of XTL-...f this Phase I trial concludes our research on the xtl legacy compounds that we inherited. Through an agg...
XTL in Biological Technology

Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. All of the resolutions at the EGMs were passed. The current board of directors consists of Mark...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)

VALLEY COTTAGE, N.Y., Oct. 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. The outcome of the EGMs was as follows: all of the resolutions passed and Jennifer L. Good ...

XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market

VALLEY COTTAGE, New York, September 26 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced that on September 24, 2007, the Company received a NASDAQ Staff Determination indicating that the Company fails to comply with the minimum $10 mill...

Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, New York, September 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) will hold a conference call today, September 11, 2007, at 8:30 a.m. EDT to discuss the Phase IIb clinical trial of Bicifadine for the treatment of diabetic neuropa...

XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...f all of our stakeholders." Ron Bentsur has more than a decade of experience in the biotech industry. Most recently, Mr. Bentsur served as CEO of xtl Biopharmaceuticals, a position he held from January 2006 until April 2009. Prior to his tenure at XTL, Mr. Bentsur was with the Company from 2000-200...

XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel

...EHOVOT, Israel, April 16 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XT... proceed with the delisting process. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009

... VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in a...

XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors

...Mr. Shweiger received an LL.B, magna cum laude, from the College of Management and an MBA in finance and auditing from Tel - Aviv University . xtl also announced that its appeal hearing date for its Nasdaq listing has been changed to March 19, 2009 from March 12, 2009. Cautionary Statemen...
Other Tags
(Date:7/9/2014)... Researchers have found that fecal transplantation is effective and ... patients. This is the result of a study led ... for Women,s Gastrointestinal Medicine at The Women,s Medicine Collaborative. ... in advance of print in the American Journal ... C. diff , has increased to epidemic proportions ...
(Date:7/9/2014)... feelings are personal and subjective, the human brain ... represents emotions across different senses, situations and even ... neuroscientist Adam Anderson. , "We discovered that fine-grained ... an area of the brain associated with emotional ... an individual,s subjective feeling," says Anderson, associate professor ...
(Date:7/9/2014)... Montefiore Medical Center and the Albert ... present new findings at the Alzheimer,s Association International Conference ... Copenhagen, Denmark. Data from the four abstracts will focus ... to mild cognitive impairment and dementia. The research is ... in 1980 to examine healthy brain aging as well ...
(Date:7/9/2014)... and have a reputation for being highly toxic, but when ... being being found to offer potential health benefits in a ... dementia. A new compound (AP39), designed and made at the ... by targeting delivery of very small amounts of the substance ... Scientists in Exeter have already found that the compound protects ...
(Date:7/9/2014)... study conducted by researchers at Tufts University School of ... intellectual and developmental disabilities, the likelihood of having cavities ... increased. The findings, published in the July/August issue of ... interventions designed to address the oral health of individuals ... dental records of 107 patients at one of the ...
Breaking Medicine News(10 mins):Health News:Women's Medicine Collaborative examines safety of fecal transplant to treat C. difficile 2Health News:Study cracks how the brain processes emotions 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 2Health News:Investigators from Montefiore and Einstein to present data at 2014 Alzheimer's Association International Conference 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3
(Date:7/9/2014)... Tampa, Fla. (July 9, 2014) Emerging fungal ... any other parasitic group, causing population declines of ... from the University of South Florida published in ... amphibians can acquire behavioral or immunological resistance to ... population declines. , "Acquired resistance is important ...
(Date:7/9/2014)... Researchers from The Cancer Genome Atlas (TCGA) Research ... cancer-causing pathway in lung adenocarcinoma, the most common ... changes may expand the number of possible therapeutic ... greater number of patients with treatable mutations because ... already exist. , TCGA is jointly funded and ...
(Date:7/9/2014)... new study shows that some shark species may be able ... may come with rising temperatures. , The Arctic today is ... it wasn,t always like that. Roughly 53 to 38 million ... the Arctic was more similar to a huge temperate forest ... including ancestors of tapirs, hippo-like creatures, crocodiles and giant tortoises. ...
Breaking Biology News(10 mins):USF study: Amphibians can acquire resistance to deadly fungus 2Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3Shark teeth analysis provides detailed new look at Arctic climate change 2Shark teeth analysis provides detailed new look at Arctic climate change 3
Other Contents